Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Epac2 Elevation Reverses Inhibition by Chondroitin Sulfate Proteoglycans In Vitro and Transforms Postlesion Inhibitory Environment to Promote Axonal Outgrowth in an Ex Vivo Model of Spinal Cord Injury.

Guijarro-Belmar A, Viskontas M, Wei Y, Bo X, Shewan D, Huang W.

J Neurosci. 2019 Oct 16;39(42):8330-8346. doi: 10.1523/JNEUROSCI.0374-19.2019. Epub 2019 Aug 13.

PMID:
31409666
2.

The cAMP-producing agonist beraprost inhibits human vascular smooth muscle cell migration via exchange protein directly activated by cAMP.

McKean JS, Murray F, Gibson G, Shewan DA, Tucker SJ, Nixon GF.

Cardiovasc Res. 2015 Sep 1;107(4):546-55. doi: 10.1093/cvr/cvv176. Epub 2015 Jun 19.

3.

Mammalian growth cone turning assays identify distinct cell signalling mechanisms that underlie axon growth, guidance and regeneration.

Murray AJ, Peace AG, Tucker SJ, Shewan DA.

Methods Mol Biol. 2012;846:167-78. doi: 10.1007/978-1-61779-536-7_15.

PMID:
22367810
4.

VEGF signaling through neuropilin 1 guides commissural axon crossing at the optic chiasm.

Erskine L, Reijntjes S, Pratt T, Denti L, Schwarz Q, Vieira JM, Alakakone B, Shewan D, Ruhrberg C.

Neuron. 2011 Jun 9;70(5):951-65. doi: 10.1016/j.neuron.2011.02.052.

5.

In vitro modelling of Alzheimer's disease: degeneration and cell death induced by viral delivery of amyloid and tau.

Stoppelkamp S, Bell HS, Palacios-Filardo J, Shewan DA, Riedel G, Platt B.

Exp Neurol. 2011 Jun;229(2):226-37. doi: 10.1016/j.expneurol.2011.01.018. Epub 2011 Feb 2.

PMID:
21295028
6.

New perspectives in cyclic AMP-mediated axon growth and guidance: The emerging epoch of Epac.

Peace AG, Shewan DA.

Brain Res Bull. 2011 Mar 10;84(4-5):280-8. doi: 10.1016/j.brainresbull.2010.09.002. Epub 2010 Sep 21. Review.

PMID:
20851749
7.

cAMP-dependent axon guidance is distinctly regulated by Epac and protein kinase A.

Murray AJ, Tucker SJ, Shewan DA.

J Neurosci. 2009 Dec 9;29(49):15434-44. doi: 10.1523/JNEUROSCI.3071-09.2009.

8.

cGMP promotes neurite outgrowth and growth cone turning and improves axon regeneration on spinal cord tissue in combination with cAMP.

Murray AJ, Peace AG, Shewan DA.

Brain Res. 2009 Oct 19;1294:12-21. doi: 10.1016/j.brainres.2009.07.071. Epub 2009 Jul 29.

PMID:
19646425
9.

Epac mediates cyclic AMP-dependent axon growth, guidance and regeneration.

Murray AJ, Shewan DA.

Mol Cell Neurosci. 2008 Aug;38(4):578-88. doi: 10.1016/j.mcn.2008.05.006. Epub 2008 May 20.

PMID:
18583150
10.
11.
12.

Axon behaviour at Schwann cell - astrocyte boundaries: manipulation of axon signalling pathways and the neural adhesion molecule L1 can enable axons to cross.

Adcock KH, Brown DJ, Shearer MC, Shewan D, Schachner M, Smith GM, Geller HM, Fawcett JW.

Eur J Neurosci. 2004 Sep;20(6):1425-35.

PMID:
15355310
13.

Age-related changes underlie switch in netrin-1 responsiveness as growth cones advance along visual pathway.

Shewan D, Dwivedy A, Anderson R, Holt CE.

Nat Neurosci. 2002 Oct;5(10):955-62.

PMID:
12352982
14.

Ephrin-B regulates the Ipsilateral routing of retinal axons at the optic chiasm.

Nakagawa S, Brennan C, Johnson KG, Shewan D, Harris WA, Holt CE.

Neuron. 2000 Mar;25(3):599-610.

15.

Growth-cone attraction to netrin-1 is converted to repulsion by laminin-1.

Höpker VH, Shewan D, Tessier-Lavigne M, Poo M, Holt C.

Nature. 1999 Sep 2;401(6748):69-73.

PMID:
10485706
16.

Patterns of alcohol use among methadone clients in a Glasgow housing estate.

Lowe E, Shewan D.

J Psychoactive Drugs. 1999 Apr-Jun;31(2):145-54.

PMID:
10437997
17.

Maturation of the mammalian dorsal root entry zone--from entry to no entry.

Golding J, Shewan D, Cohen J.

Trends Neurosci. 1997 Jul;20(7):303-8. Review.

PMID:
9223223
18.

Ecstasy and neurodegeneration. ...such as ketamine.

Shewan D, Dalgarno P.

BMJ. 1996 Aug 17;313(7054):424. No abstract available.

19.

mCD24, a glycoprotein transiently expressed by neurons, is an inhibitor of neurite outgrowth.

Shewan D, Calaora V, Nielsen P, Cohen J, Rougon G, Moreau H.

J Neurosci. 1996 Apr 15;16(8):2624-34.

20.

Illicit use of ketamine in Scotland.

Dalgarno PJ, Shewan D.

J Psychoactive Drugs. 1996 Apr-Jun;28(2):191-9.

PMID:
8811587
21.
22.

Patterns of injecting and sharing in a Scottish prison.

Shewan D, Macpherson A, Reid MM, Davies JB.

Drug Alcohol Depend. 1995 Oct;39(3):237-43.

PMID:
8556973
23.

HIV infection in prisons. Most drug injectors stop injecting on entry to prison.

Shewan D, Reid M, Macpherson A, Davies JB.

BMJ. 1995 May 13;310(6989):1264. No abstract available.

24.
25.

Behavioural change amongst drug injectors in Scottish prisons.

Shewan D, Gemmell M, Davies JB.

Soc Sci Med. 1994 Dec;39(11):1585-6.

PMID:
7817222
26.

Axonal growth and its inhibition.

Berry M, Hall S, Shewan D, Cohen J.

Eye (Lond). 1994;8 ( Pt 2):245-54. Review. No abstract available.

PMID:
7958029
27.

Embryonic optic nerve tissue fails to support neurite outgrowth by central and peripheral neurons in vitro.

Shewan D, Berry M, Bedi K, Cohen J.

Eur J Neurosci. 1993 Jul 1;5(7):809-17.

PMID:
8281292
28.

The dual use of opioids and temazepam by drug injectors in Glasgow (Scotland).

Forsyth AJ, Farquhar D, Gemmell M, Shewan D, Davies JB.

Drug Alcohol Depend. 1993 May;32(3):277-80.

PMID:
8348877
29.

Relative changes in salivary Na+ and K+ concentrations relating to stress induction.

Hinton JW, Burton RF, Farmer JG, Rotheiler E, Shewan D, Gemmell M, Berry J, Gibson R.

Biol Psychol. 1992 May;33(1):63-71.

PMID:
1600000
30.

The impact of school-based drug education.

Coggans N, Shewan D, Henderson M, Davies JB.

Br J Addict. 1991 Sep;86(9):1099-109.

PMID:
1932881
31.

Supplemental Content

Loading ...
Support Center